PHAGERUS

Serial Number 97586869
Registration 7417182
700

Registration Progress

Application Filed
Sep 12, 2022
Under Examination
Approved for Publication
Apr 2, 2024
Published for Opposition
Apr 2, 2024
Registered
Jun 18, 2024

Trademark Image

PHAGERUS

Basic Information

Serial Number
97586869
Registration Number
7417182
Filing Date
September 12, 2022
Registration Date
June 18, 2024
Published for Opposition
April 2, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 18, 2024
Registration
Registered
Classes
042

Rights Holder

iNtRON Biotechnology, Inc.

03
Address
#701-704 Jungang Induspia
138-6 Sangdaewon-dong, Joongwon-ku
Sungnam-si,Kyeonggi-do 462-120
KR

Ownership History

iNtRON Biotechnology, Inc.

Original Applicant
03
Sungnam-si,Kyeonggi-do KR

iNtRON Biotechnology, Inc.

Owner at Publication
03
Sungnam-si,Kyeonggi-do KR

iNtRON Biotechnology, Inc.

Original Registrant
03
Sungnam-si,Kyeonggi-do KR

Legal Representation

Attorney
Susan A. Smith

USPTO Deadlines

Next Deadline
1782 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-18)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
Jun 18, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 18, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 2, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 13, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 29, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 14, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 14, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 14, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 8, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Feb 8, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 8, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 7, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 7, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 5, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Feb 2, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 2, 2024 ALIE A ASSIGNED TO LIE Loading...
Feb 2, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 2, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 2, 2024 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Feb 2, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jan 22, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jan 22, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 22, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 22, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 13, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jul 6, 2023 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jul 6, 2023 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jul 6, 2023 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jan 5, 2023 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jan 5, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jan 5, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 30, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products

Classification

International Classes
042